ESC TV Today – Your Cardiovascular News
Season 3 - Ep.2: The why and how of MRAs in Heart Failure - Managing electrical storm
Oct 10, 2024
In this engaging discussion, guests Carlos Aguiar, a leading cardiology expert, Sana Al-Khatib from Duke University, and Rudolf de Boer from Erasmus University dive into the intricacies of heart failure treatment. They clarify which mineralocorticoid receptor antagonists (MRAs) suit different heart failure patients. Sana tackles the complex management of electrical storms, while Rudolf sheds light on the use of aldosterone antagonists. The group also debunks myths, like garlic's role in heart health, ensuring listeners stay well-informed on vital cardiovascular topics.
22:39
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Incorporating late gadolinium enhancement assessments in non-ischemic dilated cardiomyopathy can improve risk stratification for cardiovascular mortality.
- Managing electrical storms effectively often requires a combination of antiarrhythmic medications and potential escalation to catheter ablation for stabilization.
Deep dives
Late Gadolinium Enhancement in Cardiomyopathy
Recent studies highlight the significance of late gadolinium enhancement in patients with non-ischemic dilated cardiomyopathy, linking it to adverse outcomes, including increased mortality. Findings reveal that the presence and extent of enhancement detected through cardiac magnetic resonance imaging correlate strongly with higher all-cause and cardiovascular mortality. In contrast, left ventricular ejection fraction showed no association with these mortality outcomes. This evidence suggests that incorporating gadolinium enhancement assessments could improve the risk stratification for patients, especially when considering prophylactic ICD implantation.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
